A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors

Clinical trial NCT02576431 · COMPLETED

Trial details

NCT number: NCT02576431
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Solid Tumors Harboring NTRK Fusion

Start date: 2015-09-30
Primary completion: 2025-09-29
Enrollment: 215

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.